BCI-215
CAS: 1245792-67-9
Ref. 3D-VZB79267
| 5mg | Descontinuado | ||
| 10mg | Descontinuado | ||
| 25mg | Descontinuado | ||
| 50mg | Descontinuado | ||
| 100mg | Descontinuado |
Informação sobre produto
Nome:
BCI-215
Sinónimos:
- 1H-Inden-1-one, 5-bromo-3-(cyclohexylamino)-2,3-dihydro-2-(phenylmethylene)-, (2E)-
- (2E)-5-Bromo-3-(cyclohexylamino)-2,3-dihydro-2-(phenylmethylene)-1H-inden-1-one
Descrição:
BCI-215 is a small molecule inhibitor of the extracellular phosphatase, which is an enzyme that dephosphorylates proteins. It has been shown to inhibit the growth of cancer cells. BCI-215 has also been shown to inhibit the activation of mammalian cells, and it can be used in tumorigenicity studies. BCI-215 activates MAP kinase activity in mammalian cells and inhibits growth factor receptor tyrosine kinases. BCI-215 has been targeted for profiling by high throughput screening methods using phosphatases as bait molecules. This drug has demonstrated a phenotype of activating cellular signaling pathways through protein phosphorylation and inhibition of extracellular phosphatases.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
396.32 g/mol
Fórmula:
C22H22BrNO
Pureza:
Min. 95%
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
